Page last updated: 2024-10-25

cimetidine and Peritoneal Neoplasms

cimetidine has been researched along with Peritoneal Neoplasms in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kokubun, M1
Fujimoto, S1
Shrestha, RD1
Kobayashi, K1
Kiuchi, S1
Konno, C1
Ohta, M1
Takahashi, M1

Other Studies

1 other study available for cimetidine and Peritoneal Neoplasms

ArticleYear
[Prevention of scald injury due to intraperitoneal hyperthermic perfusion for far-advanced gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11

    Topics: Body Temperature; Burns; Cimetidine; Female; Histamine; Humans; Hyperthermia, Induced; Infusions, Pa

1991